Continuous ambulatory peritoneal dialysis in type II diabetics. 1993

S S Wei, and G S Lee, and K T Woo, and C H Lim
Department of Renal Medicine, Singapore General Hospital.

Forty-two Type II diabetic patients with end stage renal failure who had never previously received dialysis treatment were treated with continuous ambulatory peritoneal dialysis (CAPD) for a period of two to 48 months (average 16.8 months) with a total experience of 640 patient-months. Of the 42 patients, 29 (69%) were male and 13 (31%) were female. The mean duration of diabetes before dialysis was 12 years. Eleven patients (40%) were on dietary control alone, seven patients (24%) on oral hypoglycaemic control and ten patients (36%) on insulin treatment. Blood glucose control between these groups did not differ significantly. There was a significant gain in dry weight from a mean of 60.3 kg prior to dialysis to 74 kg two years after dialysis. There was no significant improvement in the haemoglobin level. Blood triglyceride levels increased from 214 +/- 63 mgm/dl to 283 mgm +/- 156 mgm/dl with an insignificant reduction in the cholesterol level. Serum calcium levels increased significantly from 8.0 +/- 1.3 to 9.1 +/- 1.0 mgm/dl in 12 months (p < 0.05). Serum alkaline phosphatase level remained stable. Blood pressure was stable throughout the dialysis period. Adequacy of dialysis clearance was shown by the mean value of serum urea 115 +/- 40 mgm/dl, serum creatinine 10.6 +/- 2.7 mgm/dl and serum phosphate 4.65 +/- 1.6 mgm/dl after two years on CAPD. No peritoneal membrane failure was reported.(ABSTRACT TRUNCATED AT 250 WORDS)

UI MeSH Term Description Entries
D007328 Insulin A 51-amino acid pancreatic hormone that plays a major role in the regulation of glucose metabolism, directly by suppressing endogenous glucose production (GLYCOGENOLYSIS; GLUCONEOGENESIS) and indirectly by suppressing GLUCAGON secretion and LIPOLYSIS. Native insulin is a globular protein comprised of a zinc-coordinated hexamer. Each insulin monomer containing two chains, A (21 residues) and B (30 residues), linked by two disulfide bonds. Insulin is used as a drug to control insulin-dependent diabetes mellitus (DIABETES MELLITUS, TYPE 1). Iletin,Insulin A Chain,Insulin B Chain,Insulin, Regular,Novolin,Sodium Insulin,Soluble Insulin,Chain, Insulin B,Insulin, Sodium,Insulin, Soluble,Regular Insulin
D008055 Lipids A generic term for fats and lipoids, the alcohol-ether-soluble constituents of protoplasm, which are insoluble in water. They comprise the fats, fatty oils, essential oils, waxes, phospholipids, glycolipids, sulfolipids, aminolipids, chromolipids (lipochromes), and fatty acids. (Grant & Hackh's Chemical Dictionary, 5th ed) Lipid
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D010531 Peritoneal Dialysis, Continuous Ambulatory Portable peritoneal dialysis using the continuous (24 hours a day, 7 days a week) presence of peritoneal dialysis solution in the peritoneal cavity except for periods of drainage and instillation of fresh solution. CAPD,Continuous Ambulatory Peritoneal Dialysis
D010538 Peritonitis INFLAMMATION of the PERITONEUM lining the ABDOMINAL CAVITY as the result of infectious, autoimmune, or chemical processes. Primary peritonitis is due to infection of the PERITONEAL CAVITY via hematogenous or lymphatic spread and without intra-abdominal source. Secondary peritonitis arises from the ABDOMINAL CAVITY itself through RUPTURE or ABSCESS of intra-abdominal organs. Primary Peritonitis,Secondary Peritonitis,Peritonitis, Primary,Peritonitis, Secondary
D001786 Blood Glucose Glucose in blood. Blood Sugar,Glucose, Blood,Sugar, Blood
D003924 Diabetes Mellitus, Type 2 A subclass of DIABETES MELLITUS that is not INSULIN-responsive or dependent (NIDDM). It is characterized initially by INSULIN RESISTANCE and HYPERINSULINEMIA; and eventually by GLUCOSE INTOLERANCE; HYPERGLYCEMIA; and overt diabetes. Type II diabetes mellitus is no longer considered a disease exclusively found in adults. Patients seldom develop KETOSIS but often exhibit OBESITY. Diabetes Mellitus, Adult-Onset,Diabetes Mellitus, Ketosis-Resistant,Diabetes Mellitus, Maturity-Onset,Diabetes Mellitus, Non-Insulin-Dependent,Diabetes Mellitus, Slow-Onset,Diabetes Mellitus, Stable,MODY,Maturity-Onset Diabetes Mellitus,NIDDM,Diabetes Mellitus, Non Insulin Dependent,Diabetes Mellitus, Noninsulin Dependent,Diabetes Mellitus, Noninsulin-Dependent,Diabetes Mellitus, Type II,Maturity-Onset Diabetes,Noninsulin-Dependent Diabetes Mellitus,Type 2 Diabetes,Type 2 Diabetes Mellitus,Adult-Onset Diabetes Mellitus,Diabetes Mellitus, Adult Onset,Diabetes Mellitus, Ketosis Resistant,Diabetes Mellitus, Maturity Onset,Diabetes Mellitus, Slow Onset,Diabetes, Maturity-Onset,Diabetes, Type 2,Ketosis-Resistant Diabetes Mellitus,Maturity Onset Diabetes,Maturity Onset Diabetes Mellitus,Non-Insulin-Dependent Diabetes Mellitus,Noninsulin Dependent Diabetes Mellitus,Slow-Onset Diabetes Mellitus,Stable Diabetes Mellitus
D003928 Diabetic Nephropathies KIDNEY injuries associated with diabetes mellitus and affecting KIDNEY GLOMERULUS; ARTERIOLES; KIDNEY TUBULES; and the interstitium. Clinical signs include persistent PROTEINURIA, from microalbuminuria progressing to ALBUMINURIA of greater than 300 mg/24 h, leading to reduced GLOMERULAR FILTRATION RATE and END-STAGE RENAL DISEASE. Diabetic Glomerulosclerosis,Glomerulosclerosis, Diabetic,Diabetic Kidney Disease,Diabetic Nephropathy,Intracapillary Glomerulosclerosis,Kimmelstiel-Wilson Disease,Kimmelstiel-Wilson Syndrome,Nodular Glomerulosclerosis,Diabetic Kidney Diseases,Glomerulosclerosis, Nodular,Kidney Disease, Diabetic,Kidney Diseases, Diabetic,Kimmelstiel Wilson Disease,Kimmelstiel Wilson Syndrome,Nephropathies, Diabetic,Nephropathy, Diabetic,Syndrome, Kimmelstiel-Wilson
D005260 Female Females

Related Publications

S S Wei, and G S Lee, and K T Woo, and C H Lim
July 1994, Clinical nephrology,
S S Wei, and G S Lee, and K T Woo, and C H Lim
March 1981, Medizinische Klinik,
S S Wei, and G S Lee, and K T Woo, and C H Lim
January 1988, Nephrologie,
S S Wei, and G S Lee, and K T Woo, and C H Lim
October 1981, British medical journal (Clinical research ed.),
S S Wei, and G S Lee, and K T Woo, and C H Lim
January 1991, Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis,
S S Wei, and G S Lee, and K T Woo, and C H Lim
March 1982, The New England journal of medicine,
S S Wei, and G S Lee, and K T Woo, and C H Lim
July 1999, Polskie Archiwum Medycyny Wewnetrznej,
S S Wei, and G S Lee, and K T Woo, and C H Lim
October 1982, The New England journal of medicine,
S S Wei, and G S Lee, and K T Woo, and C H Lim
January 1997, Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis,
S S Wei, and G S Lee, and K T Woo, and C H Lim
January 1983, Proceedings of the European Dialysis and Transplant Association. European Dialysis and Transplant Association,
Copied contents to your clipboard!